Naroa Serna

Bellaterra, CT 08193, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Targeting the chemokine receptor CXCR4 for cancer therapies.

Targeting the chemokine receptor CXCR4 for cancer therapies.

Journal: Biomarker research
Published: February 03, 2025

Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation.

Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation.

Journal: Pharmaceutics
Published: October 23, 2023

High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles.

High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles.

Journal: Acta biomaterialia
Published: May 25, 2023

Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.

Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 04, 2023

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.

Journal: Pharmaceutics
Published: January 31, 2023

Endosomal escape for cell-targeted proteins. Going out after going in.

Endosomal escape for cell-targeted proteins. Going out after going in.

Journal: Biotechnology advances
Published: November 01, 2022

The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles.

The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles.

Journal: Pharmaceutics
Published: October 03, 2022

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.

Journal: Drug delivery
Published: May 09, 2022

Protein scaffolds in human clinics.

Protein scaffolds in human clinics.

Journal: Biotechnology advances
Published: April 30, 2022

An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials.

An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials.

Journal: International journal of molecular sciences
Published: April 01, 2022

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model.

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model.

Journal: Pharmaceutics
Published: March 15, 2022

A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent mice.

A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 21, 2022
Showing 1-12 of 50

Last Updated: 09/26/2026